Publications in collaboration with researchers from Moscow City Oncology Hospital №62 (1)

2010

  1. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): A phase 4 study

    The Lancet Oncology, Vol. 11, Núm. 8, pp. 733-740